Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Micronised fenofibrate preferred for hyperlipidaemia

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Micronised fenofibrate preferred for hyperlipidaemia. Pharmacoecon. Outcomes News 128, 9 (1997). https://doi.org/10.1007/BF03271969

    Download citation

    Keywords

    • Cost Effectiveness
    • Simvastatin
    • Triglyceride Level
    • Fenofibrate
    • Concomitant Medication